null

Anti-IL13 (Lebrikizumab biosimilar) mAb (HDBS0595)

SKU:
HDBS0595
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Size:
100 μg
Target:
IL13
Isotype:
IgG4
Host Species:
Whole mAb
Reactivity:
Human
$515

Description

system_update_altDatasheetsystem_update_altMSDS
Product Name:Anti-IL13 (Lebrikizumab biosimilar) mAb
SKU:HDBS0595
Size:100 μg
Target:IL13
Common Name:DRM 06;DRM-06;DRM06;DRM 6;DRM-6;DRM6;LY 3650150;LY-3650150;LY3650150;MILR1444A;MILR-1444A;MILR 1444;ARG 3637;ARG-3637;ARG3637;RO 5490255;RO-5490255;RO5490255;TNX 650;TNX-650;TXN650
Isotype:IgG4
Host Species:Whole mAb
Reactivity:Human
Synonyms:P600;IL-13;NC30
Conjugate:Unconjugated

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Uniprot:P35225
Formulation & Reconstitution:Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Usage:Research use only
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Related Products